In a large scale of clinical blood samples from cancer patients, plasma Netrin-1 levels are significantly higher in breast, renal, prostate, liver, meningioma, pituitary adenoma, and glioblastoma cancers than it in controls (Ramesh et al., 2011). Here, NTN1 is linked to meningioma.